Pathology Imaging Systems Global Market Report 2026

Pathology imaging systems are advanced digital imaging technologies and platforms developed to capture, store, evaluate, and distribute high-resolution images of tissue specimens and laboratory samples for diagnostic purposes. These systems enhance the efficiency and precision of disease detection, particularly in cases involving cancer and chronic illnesses, through the use of digital pathology and artificial intelligence-assisted analysis. They support healthcare professionals in making faster and more accurate diagnostic decisions.

The primary components of pathology imaging systems consist of hardware, software, and services. Hardware includes sophisticated imaging equipment designed to capture, process, and evaluate high-resolution digital pathology images for both diagnostic and research applications. These systems utilize technologies such as artificial intelligence-driven systems, machine learning-integrated systems, and traditional digital imaging platforms and are implemented through on-premises and cloud-based deployment models. They support applications such as academic research and clinical diagnostics and are utilized by end users including hospitals, diagnostic laboratories, and research institutions.

Tariffs are influencing the pathology imaging systems market by raising the cost of imported scanners, high-resolution cameras, and advanced imaging software components used in digital pathology workflows. This is increasing procurement expenses for hospitals, diagnostic laboratories, and research organizations, especially in import-dependent regions such as Asia-Pacific and Latin America. The impact is particularly strong in hardware-heavy segments such as imaging devices and scanning systems within the hardware category, along with cloud-based deployment infrastructure that depends on cross-border data exchange and service integration. However, tariffs are also pushing local manufacturing of imaging hardware, encouraging regional supplier diversification, and accelerating investment in domestic digital pathology ecosystems, which may enhance long-term supply chain resilience.

The pathology imaging systems market size has grown rapidly in recent years. It will grow from $1.37 billion in 2025 to $1.52 billion in 2026 at a compound annual growth rate (CAGR) of 10.7%. The growth in the historic period can be attributed to reliance on manual microscopy processes, limited adoption of digital pathology solutions, high costs associated with imaging scanner systems, shortage of qualified pathologists, and insufficient data storage infrastructure.

The pathology imaging systems market size is expected to see rapid growth in the next few years. It will grow to $2.3 billion in 2030 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to the adoption of AI-assisted diagnostic systems, expansion of cloud-based pathology platforms, rising demand for precision medicine approaches, growth in remote diagnostic and telepathology services, and integration of hospital IT systems with imaging ecosystems. Major trends in the forecast period include increasing adoption of telepathology and remote diagnostic outsourcing models, rising demand for whole-slide imaging standardization and interoperability, expansion of centralized pathology laboratories across multi-hospital networks, growing regulatory focus on digital pathology validation and diagnostic accuracy standards, and increased integration of laboratory information systems with imaging workflows.

The expansion of clinical trial activities is expected to propel the growth of the pathology imaging systems market going forward. Clinical trial activities refer to the structured process of conducting research studies involving human participants to assess the safety and effectiveness of new drugs, therapies, medical devices, and diagnostic tools. The rising volume of clinical trials is primarily driven by increased pharmaceutical and biotechnology research and development investments, as companies along with government bodies accelerate efforts to discover new treatments across a broad spectrum of diseases. This increase in clinical trial activity strengthens demand for pathology imaging systems, as these systems play a vital role in accurate tissue examination, biomarker detection, and real-time tracking of patient outcomes within research environments. For instance, in December 2024, according to the Association of the British Pharmaceutical Industry, a UK-based trade association, the number of pharmaceutical industry trials initiated in the UK rose for the second consecutive year, increasing from 411 in 2022 to 426 in 2023. Therefore, the expansion of clinical trial activities is driving the growth of the pathology imaging systems market.

Key companies operating in the pathology imaging systems market are focusing on developing advanced solutions, such as AI-powered quality control software, to enhance image consistency, reduce manual intervention, and improve laboratory workflow efficiency. AI-powered quality control software refers to intelligent imaging technology that automatically detects scanning artifacts and image quality issues during slide digitization, helping laboratories minimize rework and improve diagnostic precision. For example, in March 2026, Leica Biosystems, a US-based provider of anatomic and digital pathology solutions, launched the Aperio GT Elite scanner along with Aperio iQC software. The solution integrates AI-powered quality control directly into the digital pathology workflow, enabling automatic detection of whole-slide imaging artifacts while slides remain on the scanner. The system offers high-throughput slide processing, barcode-driven automation, and faster quality control review, supporting improved laboratory efficiency, workflow standardization, and enhanced pathology imaging performance.

In June 2024, Quest Diagnostics, a US-based provider of diagnostic information services and laboratory testing solutions, acquired the laboratory assets of PathAI Diagnostics from PathAI for an undisclosed amount. Through this acquisition, Quest Diagnostics seeks to speed up the implementation of artificial intelligence and digital pathology technologies in order to improve cancer diagnosis and enhance diagnostic efficiency across its pathology network. PathAI is a US-based company offering AI-powered digital pathology solutions, including advanced imaging capabilities, data analytics, and diagnostic support services for pathology laboratories and biopharmaceutical organizations.

Major companies operating in the pathology imaging systems market are F. Hoffmann-La Roche AG, FUJIFILM Corporation, Philips Healthcare, GE HealthCare Technologies Inc., Agilent Technologies Inc., Olympus Corporation, Carl Zeiss Meditec AG, Hamamatsu Photonics K.K., Huron Technologies International Inc., Leica Biosystems Nussloch GmbH, Motic Xiamen Medical Diagnostic Systems Co. Ltd., Sectra AB, Sakura Finetek Japan Co. Ltd., Akoya Biosciences Inc., OptraSCAN Inc., Visiopharm A/S, Indica Labs LLC, SPOT Imaging, Objective Imaging Ltd., Corista LLC, Glencoe Software Inc., Paige.ai, PathAI, Proscia, Ibex Medical Analytics, Tribun Health

North America was the dominant region in the pathology imaging systems market in 2025. Asia-Pacific is expected to be the rapidly expanding regionin the forecast period. The regions covered in the pathology imaging systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pathology imaging systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pathology imaging systems market consists of revenues earned by entities by providing services such as digital pathology services, image analysis services, cloud-based pathology data management services, telepathology services, system integration services, and consulting services. The market value includes the value of related goods sold by the service provider or included within the service offering. The pathology imaging systems market also includes sales of slide scanners, digital microscopes, AI-based diagnostic tools, storage systems, servers, display systems, and laboratory information systems (LIS) integration tools. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The pathology imaging systems market research report is one of a series of new reports from The Business Research Company that provides pathology imaging systems market statistics, including pathology imaging systems industry global market size, regional shares, competitors with a pathology imaging systems market share, detailed pathology imaging systems market segments, market trends and opportunities, and any further data you may need to thrive in the pathology imaging systems industry. This pathology imaging systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Pathology Imaging Systems Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses pathology imaging systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pathology imaging systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pathology imaging systems market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Component: Hardware; Software; Services
• 2) By Technology: Artificial Intelligence Based Systems; Machine Learning Enabled Systems; Conventional Digital Imaging Systems
• 3) By Deployment Mode: On Premise; Cloud Based
• 4) By Application: Academic Research; Clinical Diagnosis
• 5) By End Users: Hospitals; Diagnostic Laboratories; Research Organizations
• Subsegments:
• 1) By Hardware: Imaging Devices; Scanning Systems; Digital Cameras; Microscopes; Display Systems
• 2) By Software: Image Analysis Software; Data Management Software; Workflow Management Software; Diagnostic Software; Visualization Software
• 3) By Services: Installation Services; Maintenance Services; Training Services; Consulting Services; Technical Support Services
• Companies Mentioned: F. Hoffmann-La Roche AG; FUJIFILM Corporation; Philips Healthcare; GE HealthCare Technologies Inc.; Agilent Technologies Inc.; Olympus Corporation; Carl Zeiss Meditec AG; Hamamatsu Photonics K.K.; Huron Technologies International Inc.; Leica Biosystems Nussloch GmbH; Motic Xiamen Medical Diagnostic Systems Co. Ltd.; Sectra AB; Sakura Finetek Japan Co. Ltd.; Akoya Biosciences Inc.; OptraSCAN Inc.; Visiopharm A/S; Indica Labs LLC; SPOT Imaging; Objective Imaging Ltd.; Corista LLC; Glencoe Software Inc.; Paige.ai; PathAI; Proscia; Ibex Medical Analytics; Tribun Health
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.